...
首页> 外文期刊>Nutrition Noteworthy >The Dietary Supplement Ephedrine - Should It Be Banned?
【24h】

The Dietary Supplement Ephedrine - Should It Be Banned?

机译:膳食补充麻黄碱-应该被禁止吗?

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Ephedrine is a sympathomimetic, which stimulates the sympathetic nervous system and increases the rate and strength of heart contractions. Presently, it is an immensely popular ingredient in dietary supplements (over three billion servings a year in 1999) known for its ability to decrease body weight and body fat. However the side effects of the ephedra alkaloids have not gone without notice. Annals of Internal Medicine in March 2003 found that 64% of all the adverse reactions such as stroke, seizure and myocardial infarction reported to poison control centers around the country that deal with the herbal supplements had to do with ephedra. This staggering number as well as some high profile deaths temporally linked to the use of ephedrine supplements has added to the controversy calling for a ban of the supplements. Studies into the cardiovascular effects of ephedrine ingestion (< 60 mg) have shown mixed results. Because ephedra is an herb, only if the FDA proves a clear danger to public health can it curb sales. Therefore the controversy lingers, calling for a universal standard of proper dosage and proper labeling so that more evidence can be gathered to determine the safety of the popular supplement.
机译:麻黄碱是一种拟交感神经药,可刺激交感神经系统并增加心脏收缩的速度和强度。目前,它是膳食补充剂中的一种非常受欢迎的成分(1999年每年超过30亿份),以其减轻体重和减少体内脂肪的能力而闻名。然而,麻黄生物碱的副作用并非没有引起注意。 2003年3月,《内科学年鉴》发现,向全国中毒控制中心报告的所有中草药,癫痫发作和心肌梗塞等不良反应中,有64%与麻黄有关。这一惊人的数字以及暂时与使用麻黄碱补充剂相关的一些引人注目的死亡,加剧了人们对禁止使用该补充剂的争议。摄入麻黄碱(<60 mg)对心血管的影响的研究结果好坏参半。因为麻黄是一种草药,所以只有FDA证明对公众健康构成明显危险,才能遏制麻黄的销售。因此,争议持续存在,要求制定适当剂量和适当标签的通用标准,以便可以收集更多证据来确定这种流行补品的安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号